SHEA leaders inform public policy by providing congressional testimony and correspondence before federal government agencies and Congressional committees. This section includes copies of those documents, which SHEA has sent or joined on.
Authors: APIC, SHEA
Date Published: July 21, 2020
A July 16 letter on behalf of SHEA and APIC to Vice President Mike Pence, Coronavirus Task Force Coordinator Dr. Deborah Birx, and HHS Secretary Alex Azar emphasizing the importance of using NSHN for reporting COVID-19 data.
Authors: SHEA, APIC, SIDP
Date Published: March 23, 2020
SHEA submitted joint testimony with APIC and SIDP to the U.S. House of Representatives Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies on Fiscal Year 2021 Appropriations for the U.S. Department of Health and Human Services (HHS). This includes SHEA, APIC, and SIDP federal funding priorities related to HAI prevention/research and antimicrobial resistance.
Author: SHEA, APIC
Date Published: June 03, 2019
SHEA submitted joint testimony with APIC to the U.S. Senate Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies on Fiscal Year 2020 Appropriations for the U.S. Department of Health and Human Services (HHS). This includes SHEA and APIC federal funding priorities related to HAI prevention/research and antimicrobial resistance.
Author: SHEA, APIC
Date Published: April 15, 2016
SHEA submitted joint testimony with APIC to the U.S. House of Representatives Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies on Fiscal Year 2017 Appropriations for the U.S. Department of Health and Human Services (HHS). This includes SHEA and APIC federal funding priorities related to HAI prevention/research and antimicrobial resistance.
SHEA expertise is routinely sought by regulatory and legislative entities. This section showcases regulatory letters and comments.